TMCI (TMCI) Stock Price & Analysis
TMCI (TMCI) fell 1.43% to USD 4.81 as of September 8, 2026 at 04:23 UTC, according to Nexqual real-time market data.
TMCI last closed at USD 4.81; the session ranged USD 4.72–4.87 on volume of 231,834 shares. Market capitalization is —, with a 52-week range of USD 1.17–7.63 (NMS). Source: Nexqual, September 8, 2026 at 04:23 UTC.
Key Statistics (as of September 8, 2026 at 04:23 UTC)
| Price | USD 4.81 |
|---|---|
| Change | ▼ 1.43% (down) |
| Previous Close | USD 4.81 |
| Open | USD 4.81 |
| Day Range | USD 4.72 – 4.87 |
| 52-Week Range | USD 1.17 – 7.63 |
| Volume | 231,834 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (TMCI)
Nexqual's technical model rates TMCI "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 04:23 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 57.23 (neutral) |
| vs SMA50 | Above (USD 4.46) |
| MACD | 0.1 (positive) |
From TMCI's Latest SEC 10-K Filing (filed 2026-02-27)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SGHT | Sight Sciences, Inc. | USD 8.35 | ▼ 0.83% |
| CTKB | Cytek Biosciences, Inc. | USD 4.7 | ▲ 0.21% |
| DSGN | Design Therapeutics, Inc. | USD 15.14 | ▼ 2.51% |
| LUNG | Pulmonx Corporation | USD 2.21 | ▼ 3.07% |
| CVRX | CVRx, Inc. | USD 3.05 | ▼ 0.65% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 04:23 UTC. This page is informational and not investment advice.